Type III Interferons, IL-28 and IL-29, Are Increased in Chronic HCV Infection and Induce Myeloid Dendritic Cell-Mediated FoxP3+ Regulatory T Cells

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Dolganiuc, Angela ^a   Kodys, Karen ^a   Marshall, Christopher ^a   Saha, Banishree ^a   Zhang, Shuye ^a   Bala, Shashi ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON LAMBDA; INTERFERON LAMBDA RECEPTOR; INTERFERON TYPE 3; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR 2; INTERLEUKIN 28; INTERLEUKIN 29; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; LEUKOCYTE; LIVER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MYELOID DENDRITIC CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMATOID DENDRITIC CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS NEUTRALIZATION;

ADULT; CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, INNATE; INTERLEUKINS; LIVER; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, INTERFERON; T-LYMPHOCYTES, REGULATORY;

EID: 84867354111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044915     Document Type: Article

References (25)

1. Muhlberger N, Schwarzer R, Lettmeier B, Sroczynski G, Zeuzem S, et al. (2009) HCV-related burden of disease in europe: A systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 9: 34.
2. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, et al. (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347(13): 975-982.
3. Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, et al. (2011) Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 54(6): 1913-1923.
4. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, et al. (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131(6): 1887-1898.
5. Uze G, Monneron D, (2007) IL-28 and IL-29: newcomers to the interferon family. Biochimie 89: 729-734.
6. Donnelly RP, Dickensheets H, O'Brien TR, (2011) Interferon-lambda and therapy for chronic hepatitis C virus infection. Trends Immunol 32(9): 443-450.
7. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461(7265): 798-801.
8. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4(1): 69-77.
9. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, et al. (2006) Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44(4): 896-906.
10. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461(7262): 399-401.
11. Szabo G, Dolganiuc A (2008) Hepatitis C and innate immunity: Recent advances. Clin Liver Dis 12(3): 675-92, x.
12. Dolganiuc A, Paek E, Kodys K, Thomas J, Szabo G, (2008) Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 135(6): 2119-2127.
13. Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A, (2010) Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 52(3): 315-321.
14. Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, et al. (2010) Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci (Lond). 119(2): 97-109.
15. Dolganiuc A, Szabo G, (2008) T cells with regulatory activity in hepatitis C virus infection: What we know and what we don't. J Leukoc Biol 84(3): 614-622.
16. Chang S, Kodys K, Szabo G, (2010) Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 51(1): 35-42.
17. Yang L, Wei J, He S, (2010) Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction. Int J Mol Med. 25(2): 299-304.
18. Perrella A, Vitiello L, Atripaldi L, Conti P, Sbreglia C, et al. (2006) Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. Gut 55(9): 1370-1371.
19. Diegelmann J, Beigel F, Zitzmann K, Kaul A, Goke B, et al. (2010) Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus. PLoS One 5(12): e15200.
20. Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, et al. (2011) Interferon-lambda serum levels in hepatitis C. J Hepatol. 54(5): 859-865.
21. Rallón NI, Soriano V, Naggie S, Restrepo C, McHutchison J, et al. (2010) Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV. J Antimicrob Chemother. May 67(5): 1246-9.
22. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, et al. (2006) Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol. May 80(9): 4501-9.
23. Miyatake H, Kanto T, Inoue M, Sakakibara M, Kaimori A, et al. (2007) Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection. J Viral Hepat 14(6): 404-412.
24. Bolacchi F, Sinistro A, Ciaprini C, Demin F, Capozzi M, et al. (2006) Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 144(2): 188-196.
25. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, et al. (2007) Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81(14): 7749-7758.